Literature DB >> 19429868

A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways.

Chris I Jones1, Sarah Bray, Stephen F Garner, Jonathan Stephens, Bernard de Bono, Will G J Angenent, David Bentley, Philippa Burns, Alison Coffey, Panos Deloukas, Mark Earthrowl, Richard W Farndale, Marc F Hoylaerts, Kerstin Koch, Angela Rankin, Catherine M Rice, Jane Rogers, Nilesh J Samani, Michael Steward, Adam Walker, Nicholas A Watkins, Jan-Willem Akkerman, Frank Dudbridge, Alison H Goodall, Willem H Ouwehand.   

Abstract

Platelet response to activation varies widely between individuals but shows interindividual consistency and strong heritability. The genetic basis of this variation has not been properly explored. We therefore systematically measured the effect on function of sequence variation in 97 candidate genes in the collagen and adenosine-diphosphate (ADP) signaling pathways. Resequencing of the genes in 48 European DNA samples nearly doubled the number of known single nucleotide polymorphisms (SNPs) and informed the selection of 1327 SNPs for genotyping in 500 healthy Northern European subjects with known platelet responses to collagen-related peptide (CRP-XL) and ADP. This identified 17 novel associations with platelet function (P < .005) accounting for approximately 46% of the variation in response. Further investigations with platelets of known genotype explored the mechanisms behind some of the associations. SNPs in PEAR1 associated with increased platelet response to CRP-XL and increased PEAR1 protein expression after platelet degranulation. The minor allele of a 3' untranslated region (UTR) SNP (rs2769668) in VAV3 was associated with higher protein expression (P = .03) and increased P-selectin exposure after ADP activation (P = .004). Furthermore the minor allele of the intronic SNP rs17786144 in ITPR1 modified Ca(2+) levels after activation with ADP (P < .004). These data provide novel insights into key hubs within platelet signaling networks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429868     DOI: 10.1182/blood-2009-02-202614

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  The genetics of normal platelet reactivity.

Authors:  Thomas J Kunicki; Diane J Nugent
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

2.  Akt signaling in platelets and thrombosis.

Authors:  Donna S Woulfe
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

Review 3.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

Review 4.  Genetic sequence analysis of inherited bleeding diseases.

Authors:  Flora Peyvandi; Tom Kunicki; David Lillicrap
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

5.  Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS).

Authors:  John D Eicher; Luting Xue; Yoav Ben-Shlomo; Andrew D Beswick; Andrew D Johnson
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

6.  Microfluidic assessment of functional culture-derived platelets in human thrombi under flow.

Authors:  Viraj Kamat; Ryan W Muthard; Ruizhi Li; Scott L Diamond
Journal:  Exp Hematol       Date:  2015-07-02       Impact factor: 3.084

Review 7.  Systems biology of platelet-vessel wall interactions.

Authors:  Yolande Chen; Seth Joel Corey; Oleg V Kim; Mark S Alber
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

8.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12

9.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

10.  PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways.

Authors:  Chris I Jones; Stephen F Garner; Leonardo A Moraes; William J Kaiser; Angela Rankin; Willem H Ouwehand; Alison H Goodall; Jonathan M Gibbins
Journal:  FEBS Lett       Date:  2009-10-20       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.